FAXELADOL HYDROCHLORIDE

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C15H23NO.ClH
Molecular Weight	269.81
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

Cl.CN(C)C[C@@H]1CCCC[C@H]1C2=CC(O)=CC=C2

InChI

InChIKey=SLOIWIHZXQWWIY-SLHAJLBXSA-N

InChI=1S/C15H23NO.ClH/c1-16(2)11-13-6-3-4-9-15(13)12-7-5-8-14(17)10-12;/h5,7-8,10,13,15,17H,3-4,6,9,11H2,1-2H3;1H/t13-,15-;/m0./s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22337471 | https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001404-40/DK | https://adisinsight.springer.com/drugs/800032836

Faxeladol (GRT9906) is a μ-opioid receptor agonist and inhibitor of noradrenalin/serotonin re-uptake. Faxeladol was being studied in the treatment of fibromyalgia and neuropathic pain, however its development has been discontinued.

Originator

Approval Year

PubMed

Title	Date	PubMed
Randomized controlled trial of the combined monoaminergic and opioid investigational compound GRT9906 in painful polyneuropathy.	2012-07	22337471

Patents

Sample Use Guides

In Vivo Use Guide

During 4-week treatment periods, daily oral doses of faxeladol (GRT9906) 120-240 mg

Route of Administration: Oral

Name

Type

Language

FAXELADOL HYDROCHLORIDE

Common Name

English

FAXELADOL HCL

Preferred Name

English

Classification Tree Code System Code

NCI_THESAURUS

C67413